Amrinder Singh is a Partner at Vensana Capital. Amrinder was previously a Senior Investment Director at Medtronic Ventures where he supported new investments in the medical device, diagnostics, and digital health spaces along with providing operational and board management support to portfolio companies. Prior to his investment career, Amrinder led Business Development & Strategy for Medtronic’s remote monitoring and services businesses and was previously with the corporate strategy group. Before joining Medtronic, Amrinder held product management and engineering positions at Thoratec Corporation. Amrinder currently serves on the board of directors of iVEAcare, Luna Diabetes, and Nyra Medical. Amrinder graduated from University of California, Davis in Biosystems Engineering and earned an MBA from Northwestern University, Kellogg School of Management.